NIAAA Two-Question Alcohol Screen Valid in Pediatric ERs

Share this content:
NIAAA Two-Question Alcohol Screen Valid in Pediatric ERs
NIAAA Two-Question Alcohol Screen Valid in Pediatric ERs

WEDNESDAY, Nov. 30, 2016 (HealthDay News) -- The National Institute of Alcohol Abuse and Alcoholism (NIAAA) two-question alcohol screen is valid for use within pediatric emergency departments (PEDs), according to a study published online Nov. 29 in Pediatrics.

Anthony Spirito, Ph.D., from the Warren Alpert Medical School of Brown University in Providence, R.I., and colleagues examined the psychometric properties of the NIAAA two-question alcohol screen within U.S. PEDs. Participants included 4,838 12- to 17-year-olds treated in one of 16 participating PEDs. The NIAAA two-question screen was readministered one week later to 186 participants to assess test-retest reliability.

The researchers found that there was moderate to good test-retest reliability. The best combined sensitivity and specificity for determining a diagnosis of alcohol use disorder (AUD) was a classification of moderate risk or higher on the screen. Among middle school students, any past-year drinking increased the odds of a diagnosis of an AUD; the optimal cut-off for high school ages was three or more drinking days in the past year. For determining a positive Alcohol Use Disorders Identification Test score, the optimal cutoff was one or more drinking days for middle school subjects and two or more drinking days for high school students.

"The NIAAA two-question screen is a brief, valid approach for alcohol screening in PEDs," the authors write. "A positive screen suggests that referral for further evaluation is indicated to determine if an adolescent has an AUD."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Parkinson's Add-On Drug Xadago

FDA Approves New Parkinson's Add-On Drug Xadago

To help prevent 'off' episodes among users of levodopa/carbidopa

Infant Mortality Down in United States From 2005 to 2014

Infant Mortality Down in United States From 2005 ...

Largest decreases seen for infants of Asian or Pacific Islander and non-Hispanic black women

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive alveolar recruitment strategy linked to less severe pulmonary complications after cardiac sx

is free, fast, and customized just for you!

Already a member?

Sign In Now »